Finance

Lists
524816:BOM
Natco Pharma Ltd
₹838.60
-0.53%
(-4.50) 1D
Sep 3, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524816...
Open
₹853.00
High
₹853.00
Low
₹836.00
Mkt. cap
150.15B
Avg. vol.
0.00
Volume
11.63K
Dividend
0.54%
Quarterly dividend
₹1.13
Ex-dividend date
Aug 20, 2026
P/E ratio
13.13
52-wk high
₹1,226.10
52-wk low
₹789.30
EPS
₹63.89
Shares outstanding
182.26M
No. of employees
4K
Open
₹853.00
High
₹853.00
Low
₹836.00
Mkt. cap
150.15B
Avg. vol.
0.00
Volume
11.63K
Dividend
0.54%
Quarterly dividend
₹1.13
Ex-dividend date
Aug 20, 2026
P/E ratio
13.13
52-wk high
₹1,226.10
52-wk low
₹789.30
EPS
₹63.89
Shares outstanding
182.26M
No. of employees
4K
Profile
Natco Pharma is an Indian multinational pharmaceutical company based in Hyderabad. The company manufactures finished dosage formulations, active pharmaceutical ingredients and agrochemical products. It is a major producer of branded oncology medicines cardiology, diabetology and other pharma specialty drugs at affordable prices. Wikipedia
About Natco Pharma Ltd
CEORajeev Nannapaneni
Employees4.2K
Founded1981
HeadquartersBanjara Hills, Telangana, India
SectorPharmaceutical industry
Websitenatcopharma.co.in
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
13.63B
6.47B
7.39B
7.35B
Cost of goods sold
1.70B
1.33B
1.55B
1.48B
Cost of revenue
1.70B
1.33B
1.55B
1.48B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.00B
1.59B
1.58B
1.79B
Operating expense
6.66B
4.02B
5.07B
4.48B
Total operating expenses
8.36B
5.35B
6.62B
5.96B
Operating income
5.27B
1.12B
772.00M
1.39B
Other non operating income
1.00B
581.00M
778.00M
592.00M
EBT including unusual items
6.14B
1.72B
1.80B
2.70B
EBT excluding unusual items
6.14B
1.72B
1.80B
2.70B
Income tax expense
958.00M
207.00M
-892.00M
634.00M
Effective tax rate
15.61%
12.03%
-49.61%
23.49%
Other operating expenses
4.14B
1.96B
2.98B
2.22B
Net income
5.18B
1.52B
2.68B
2.06B
Net profit margin
38.03%
23.40%
36.25%
28.09%
Earnings per share
28.94
8.46
14.96
11.53
Interest and investment income
-
-
-
-
Interest expense
-131.00M
-95.00M
-109.00M
-130.00M
Net interest expenses
-131.00M
-95.00M
-109.00M
-130.00M
Depreciation and amortization charges
524.00M
462.00M
504.00M
471.00M
EBITDA
5.82B
1.57B
1.29B
1.91B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps